Literature DB >> 24479591

Continuous glucose monitoring in 2013.

Tadej Battelino1, Bruce W Bode.   

Abstract

Entities:  

Year:  2014        PMID： 24479591      PMCID： PMC3920866          DOI： 10.1089/dia.2014.1502

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN： 1520-9156            Impact factor:   6.118


× No keyword cloud information.
  20 in total

1.  Influence of glycemic variability on the HbA1c level in elderly male patients with type 2 diabetes.

Authors:  Fu-Sheng Fang; Zhi-Bing Li; Chun-Lin Li; Hui Tian; Jian Li; Xiao-Ling Cheng
Journal:  Intern Med       Date:  2012-11-15       Impact factor: 1.271

2.  Continuous glucose monitoring and cognitive performance in type 2 diabetes.

Authors:  Karma L Pearce; Manny Noakes; Carlene Wilson; Peter M Clifton
Journal:  Diabetes Technol Ther       Date:  2012-10-09       Impact factor: 6.118

3.  Continuous glucose monitoring in young children: satisfaction without success?

Authors:  Stuart A Weinzimer
Journal:  Diabetes Technol Ther       Date:  2012-08-13       Impact factor: 6.118

4.  Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.

Authors:  S Buscemi; A Re; J A Batsis; M Arnone; A Mattina; G Cerasola; S Verga
Journal:  Diabet Med       Date:  2010-08       Impact factor: 4.359

5.  Prognostic accuracy of continuous glucose monitoring in the prediction of diabetes mellitus in children with incidental hyperglycemia: receiver operating characteristic analysis.

Authors:  Davide Brancato; Gabriella Saura; Mattia Fleres; Lidia Ferrara; Alessandro Scorsone; Vito Aiello; Anna Di Noto; Lucia Spano; Vincenzo Provenzano
Journal:  Diabetes Technol Ther       Date:  2013-04-17       Impact factor: 6.118

6.  A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.

Authors:  Mark Christiansen; Timothy Bailey; Elaine Watkins; David Liljenquist; David Price; Katherine Nakamura; Robert Boock; Thomas Peyser
Journal:  Diabetes Technol Ther       Date:  2013-06-18       Impact factor: 6.118

7.  Threshold-based insulin-pump interruption for reduction of hypoglycemia.

Authors:  Richard M Bergenstal; David C Klonoff; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew J Ahmann; John B Welsh; Scott W Lee; Francine R Kaufman
Journal:  N Engl J Med       Date:  2013-06-22       Impact factor: 91.245

8.  Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.

Authors: 
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

9.  Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus.

Authors:  Keiichi Torimoto; Yosuke Okada; Hiroko Mori; Yoshiya Tanaka
Journal:  Cardiovasc Diabetol       Date:  2013-01-02       Impact factor: 9.951

10.  Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application.

Authors:  Stephanie J Fonda; Sara J Salkind; M Susan Walker; Mary Chellappa; Nicole Ehrhardt; Robert A Vigersky
Journal:  Diabetes Care       Date:  2012-11-19       Impact factor: 19.112
View more
  3 in total

1.  Continuous glucose monitoring in 2014.

Authors:  Bruce W Bode; Tadej Battelino
Journal:  Diabetes Technol Ther       Date:  2015-02       Impact factor: 6.118

Review 2.  Type 1 Diabetes in the Young: Organization of Two National Centers in Israel and Slovenia.

Authors:  Nataša Bratina; Shlomit Shalitin; Moshe Phillip; Tadej Battelino
Journal:  Zdr Varst       Date:  2015-03-13

3.  Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.

Authors:  J Lawton; M Blackburn; J Allen; F Campbell; D Elleri; L Leelarathna; D Rankin; M Tauschmann; H Thabit; R Hovorka
Journal:  BMC Endocr Disord       Date:  2018-02-20       Impact factor: 2.763
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.